Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 29;7(1):22.
doi: 10.1186/1940-0640-7-22.

Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems

Theresa A Rowe  1 , Janet S Jacapraro, Darius A Rastegar
Affiliations

Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems

Theresa A Rowe et al. Addict Sci Clin Pract. .

Abstract

Background: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions.

Methods: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit.

Results: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year.

Conclusions: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.

PubMed Disclaimer

References

    1. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695. doi: 10.1001/jama.284.13.1689. - DOI - PubMed
    1. Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D. Office-based treatment of opiate addiction with sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949–958. doi: 10.1056/NEJMoa022164. - DOI - PubMed
    1. Bridge TP, Fudala PJ, Herbert S, Leiderman D. Safely and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence. Drug Alcohol Depend. 2003;70(Suppl 2):7079–7085. - PubMed
    1. Mintzer I, Eisenberg M, Terra M, Mac Vane C, Himmelstein D, Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5:146–150. doi: 10.1370/afm.665. - DOI - PMC - PubMed
    1. Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Brit J Pract. 2005;44:139–146. - PMC - PubMed